Pharmaceutical Giant GSK To Expand Greater Boston Footprint
Posted by Erika Tarlow on
British pharmaceutical company GSK is growing its Greater Boston lab space, having acquired an additional 155,000 sq ft to add onto their Cambridge RNA and viral therapies lab site. Their current lab is 40,000 sq ft - this acquisition will bring their Cambridge site to over 200,000 sq ft. You can read more about it here.
Boston is one of the world's fastest-growing biotech hubs, with over 9 million sq ft of lab space under construction in Boston in 2022 and additional 4.6 million sq ft to be converted. The quickly growing industry is bringing jobs to the Greater Boston market at an unprecedented rate. Increasing demand combined with very low inventory has made the market historically competitive; experience and track record matter more than…
312 Views, 0 Comments